Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre. Issue 4 (28th April 2018)
- Record Type:
- Journal Article
- Title:
- Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre. Issue 4 (28th April 2018)
- Main Title:
- Should surgery be delayed in patients taking direct oral anticoagulants who suffer a hip fracture? A retrospective, case-controlled observational study at a UK major trauma centre
- Authors:
- Mullins, Barry
Akehurst, Harold
Slattery, David
Chesser, Tim - Abstract:
- Abstract : Objective: To determine whether not waiting for the elimination of direct oral anticoagulants (DOACs) has an effect on the amount of perioperative bleeding in patients who undergo operative treatment of a hip fracture. Design: Observation, retrospective case–control study. Setting: A single UK major trauma centre. Participants: Patients who sustained a hip fracture were identified using the National Hip Fracture Database (NHFD). All those found to be taking a DOAC at the time of fracture were identified (n=63). A matched group not taking a DOAC was also identified from the NHFD (n=62). Main outcome: Perioperative drop in haemoglobin concentration. Results: There was no relationship between admission to operation interval and perioperative change in haemoglobin concentration in patients taking DOACs (regression coefficient=−0.06 g/L/hour; 95% CI −0.32–0.20; p=0.64). No relationship was found between the time from admission to operation interval and the probability of transfusion (OR=0.94; 95% CI 0.85 to 1.90; p=0.16) or reoperation (OR=1.04; 95% CI 0.93 to 1.16; p=0.49). One mortality was recorded in the DOAC group within 30 days of admission, and this compared with five in the matched group of patients (p=0.2). Conclusions: Delaying surgery in patients who sustain a hip fracture who are taking a DOAC drug has not been shown to reduce perioperative bleeding or affect their mortality in this study.
- Is Part Of:
- BMJ open. Volume 8:Issue 4(2018)
- Journal:
- BMJ open
- Issue:
- Volume 8:Issue 4(2018)
- Issue Display:
- Volume 8, Issue 4 (2018)
- Year:
- 2018
- Volume:
- 8
- Issue:
- 4
- Issue Sort Value:
- 2018-0008-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-04-28
- Subjects:
- hip fractures -- anticoagulants -- blood transfusion -- postoperative complications -- perioperative care
Medicine -- Research -- Periodicals
610.72 - Journal URLs:
- http://www.bmj.com/archive ↗
http://bmjopen.bmj.com/ ↗ - DOI:
- 10.1136/bmjopen-2017-020625 ↗
- Languages:
- English
- ISSNs:
- 2044-6055
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17676.xml